Human Gene Therapy Methods
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Key Metrics
Journal Specifications
Indexed in the following public directories
CrossRef 
SJR 
Scopus 
Web of Science
- PublisherMARY ANN LIEBERT, INC
- LanguageEnglish
- FrequencyBi-monthly
- LanguageEnglish
- FrequencyBi-monthly
- Publication Start Year2012
- Publisher URL
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Human Gene Therapy Methods been publishing? 
The Human Gene Therapy Methods has been publishing since 2012 till date.
How frequently is the Human Gene Therapy Methods published?
Human Gene Therapy Methods is published Bi-monthly.
Who is the publisher of Human Gene Therapy Methods?
The publisher of Human Gene Therapy Methods is MARY ANN LIEBERT, INC.
How can I view the journal metrics of Human Gene Therapy Methods on editage?
For the Human Gene Therapy Methods metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Human Gene Therapy Methods?
The eISSN number is 1946-6544 and pISSN number is 1946-6536 for Human Gene Therapy Methods.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Peptide display, Chimeric antigen receptor, Adeno-associated virus, Expression cassette.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.